Alyssa Romano
Velan Capital Investment Management Lp
Assets Managed
$159.645M
Holdings
49
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-7.38%(2Q avg: 27.27%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Velan Capital Investment Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 49 positions.
Assets under management
The assets under management (AUM) of Velan Capital Investment Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 159.645M in assets, with a quarterly growth rate of -7.38% and a 2-quarter average growth rate of 27.27%. The portfolio is managed by Alyssa Romano, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
PRAX Praxis Precision Medicines I
| 20.34% | $32.471M 100,781 shares@ $322.19 avg price | |
TARA Protara Therapeutic Inc
| 9.26% | $14.769M 2.835M shares@ $5.22 avg price | |
STRO Sutro Biopharma Inc
| 8% | $12.758M 512,160 shares@ $24.92 avg price | Increased 64.16% |
EVMN Evommune Inc
| 6.43% | $10.259M 446,255 shares@ $22.99 avg price | Decreased -11.93% |
MPLT Maplight Therapeutics Inc
| 6.28% | $10.021M 492,893 shares@ $20.34 avg price | Decreased -5.63% |
TENX Tenax Therapeutics Inc
| 5.85% | $9.327M 583,333 shares@ $16.0 avg price | Increased 600.01% |
ABVX Abivax Sa-adr
| 5.38% | $8.574M 77,000 shares@ $111.35 avg price | Increased 14.93% |
HRTX Heron Therapeutics Inc
| 4.39% | $7.004M 8.753M shares@ $0.81 avg price | |
IMMX Immix Biopharma Inc
| 4.23% | $6.741M 740,000 shares@ $9.11 avg price | Increased 2014.29% |
ESPR Esperion Therapeutics Inc
| 2.96% | $4.713M 1.72M shares@ $2.74 avg price | Increased 42.15% |
1-10 of 49